Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD
Clinical trial NCT03903809 · UNKNOWN
Trial details
- NCT number
- NCT03903809
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2021-10-14
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.